|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 265, Issue 1 238-H243, Copyright © 1993 by American Physiological Society
ARTICLES |
D. L. Geenen, A. Malhotra and J. Scheuer
Department of Medicine, Montefiore Medical Center, Bronx, New York 10467.
This study examined the direct effect of angiotensin II (ANG II) on cardiac muscle atrophy previously observed in the denervated rat heart. Rats with transplanted hearts were infused with normal saline (1 microliter/h) or a subpressor dose of ANG II dissolved in saline (3 micrograms.kg-1.h-1) for 1 wk. Left ventricular (LV) mass of transplanted hearts decreased by 29 and 18% in the saline-infused and ANG II-infused groups, respectively (P < 0.05). Total LV protein synthesis of the transplanted heart was 1.4 +/- 0.1 mg.LV-1.day-1 in the saline compared with 2.2 +/- 0.2 mg.LV-1.day-1 in the ANG II (P < 0.05) group. Heart rate and carotid systolic arterial pressures were not affected by ANG II infusion, and the decrease in alpha-myosin heavy chain normally observed in this model was unchanged between the two groups (61 +/- 3 and 66 +/- 1%, saline vs. ANG II). These data demonstrate that ANG II increases total cardiac protein synthesis in the adult heart, leading to an attenuation in cardiac atrophy. The failure of ANG II to prevent the shift from alpha- to beta-myosin heavy chain may be related to its lack of an effect on heart rate, since other interventions that affect myosin isoenzyme distribution also increase heart rate.
This article has been cited by other articles:
![]() |
Z. Sun, X. Wang, C. E. Wood, and J. R. Cade Genetic AT1A receptor deficiency attenuates cold-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R433 - R439. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-D. Wagner, V. Essmann, K. Mydlak, M. Wirth, G. Gmehling, J. Bohlender, H. M. Stauss, J. Gunther, I. Schimke, and H. Scholz Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R153 - R160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brink, J. Chrast, S. R. Price, W. E. Mitch, and P. Delafontaine Angiotensin II Stimulates Gene Expression of Cardiac Insulin-Like Growth Factor I and Its Receptor Through Effects on Blood Pressure and Food Intake Hypertension, November 1, 1999; 34(5): 1053 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, T. Peng, K. J. Scheidegger, and P. Delafontaine Angiotensin II Activation of Insulin-Like Growth Factor 1 Receptor Transcription Is Mediated by a Tyrosine Kinase–Dependent Redox-Sensitive Mechanism Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2119 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Harrap and J. B. O'Sullivan Cardiac Transplantation, Perindopril, and Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats Hypertension, October 1, 1996; 28(4): 622 - 626. [Abstract] [Full Text] |
||||
![]() |
R. E. Schmieder, M. R.W. Langenfeld, A. Friedrich, H. P. Schobel, C. D. Gatzka, and H. Weihprecht Angiotensin II Related to Sodium Excretion Modulates Left Ventricular Structure in Human Essential Hypertension Circulation, September 15, 1996; 94(6): 1304 - 1309. [Abstract] [Full Text] |
||||
![]() |
D. Susic, E. Nunez, E. D. Frohlich, and O. Prakash Angiotensin II Increases Left Ventricular Mass Without Affecting Myosin Isoform mRNAs Hypertension, August 1, 1996; 28(2): 265 - 268. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |